Table 1 Demographics of the study population with myasthenia gravis (N = 1149)
From: A retrospective longitudinal cohort study of the clinical burden in myasthenia gravis
Characteristic | Value |
|---|---|
Age (y), mean ± standard deviation | 63.6 ± 16.7 |
Age category (y), n (%) | |
18–39 | 136 (11.8) |
40–59 | 241 (21.0) |
60–79 | 609 (53.0) |
≥ 80 | 163 (14.2) |
Sex, n (%) | |
Male | 609 (53.0) |
Female | 540 (47.0) |
Geographic region, n (%) | |
North East | 21 (1.8) |
South East | 149 (13.0) |
North West | 165 (14.4) |
Yorkshire & The Humber | 47 (4.1) |
East Midlands | 26 (2.3) |
West Midlands | 123 (10.7) |
East of England | 144 (12.5) |
South West | 162 (14.1) |
South Central | 129 (11.2) |
London | 183 (15.9) |
Ethnicity, n (%) | |
Asian | 32 (2.8) |
Black | 17 (1.5) |
Other | 105 (9.1) |
Mixed | 5 (0.4) |
White | 990 (86.2) |
Charlson Comorbidity Index score, mean ± standard deviation | 0.7 ± 1.5 |
Charlson Comorbidity Index category, n (%) | |
0 to < 1 | 950 (82.7) |
1 to < 2 | 112 (9.7) |
2 to < 3 | 40 (3.5) |
3 to < 4 | 16 (1.4) |
≥ 4 | 31 (2.7) |